BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 30, 2005
View Archived Issues
Phase III Targretin studies in front-line NSCLC fail to meet endpoints
Read More
Antiinflammatory and antiapoptotic properties of MX-1153
Read More
Novel dihydroquinolines with broad-spectrum activity against multiple herpesviruses
Read More
Telavancin receives fast track designations
Read More
Novel human glucagon receptor antagonist discovered
Read More
FDA approval for Xibrom
Read More
iNOS inhibitor with prominent antiinflammatory effects
Read More
Full approval for Velcade in second-line multiple myeloma
Read More
Immunosuppressant agents reported by Poseidon Pharmaceuticals
Read More
Anti-IGF-1R antibody in clinical phase I trials
Read More
ACHP inhibits myeloma cell growth and sensitizes myeloma cells to chemotherapeutic agents
Read More
Enrollment suspended in Clevelox phase III safety trials
Read More
Highlights of the 15th Annual Meeting of the American Glaucoma Society
Read More
Tacrolimus 0.03% cream reported safe and effective in atopic dermatitis
Read More
Anticonvulsants show promise in the management of impulsive aggression
Read More
New atiprimod trial in advanced cancers
Read More
Phase II study of IC-485 in COPD fails to meet primary endpoint
Read More
Protein Design Labs plots Nuvion development pathway
Read More
Good safety results for Theratechnologies' GLP-1 analogue
Read More
Zilver PTX stent studied for peripheral arterial disease
Read More
New title added to Drug R&D Backgrounders series: Nicotine Addiction
Read More
Rasagiline improves fluctuations in levodopa-treated Parkinson's disease patients
Read More
New treatments for respiratory disorders described in patent literature
Read More
Chemokine CXCR3 receptor inhibitors emerge from Celltech R&D
Read More
Complement inhibitors for neurodegenerative, autoimmune disorders disclosed in recent patents
Read More